首页> 外文期刊>癌と化学療法 >A case report of intra-hepatic arterial infusion of mitomycin C with degradable starch microspheres for liver metastases of sigmoid colon carcinoma
【24h】

A case report of intra-hepatic arterial infusion of mitomycin C with degradable starch microspheres for liver metastases of sigmoid colon carcinoma

机译:丝霉素C肝癌肝脏肝癌肝脏肝脏肝脏肝脏肝脏转移酶的肝脏输注案例报告

获取原文
获取原文并翻译 | 示例
           

摘要

A 46-year-old man underwent polypectomy of sigmoid colon in January 1996. The adenocarcinoma invaded the submucosal layer, and sigmoidectomy and D2 lymph node dissection were performed one month later. Follow-up CT revealed liver metastases, and partial hepatectomy was performed in January 1998. Afterward, weekly high dose intra-hepatic arterial chemotherapy (5-FU: 1,000 mg/body) was performed 41 times, but CT revealed multiple liver metastases in October 1998. Therefore, intra-hepatic arterial infusion of mitomycin C (MMC) with degradable starch microspheres (DSM) was given in November 1998. As follow-up CT revealed that the liver metastases were growing, partial hepatectomy was performed again in March 1999. No carcinoma was seen in the resected liver. After the second hepatectomy, intra-hepatic arterial infusion of MMC with DSM was performed five times. No evidence of recurrence has been seen. Intra-hepatic arterial infusion of MMC with DSM is recommended for liver metastases of colorectal cancer asa second line treatment.
机译:1996年1月,一名46岁的男子接受了锡形结肠的综糖症。腺癌侵入了粘膜下层,并在一个月后进行了杀菌切除术和D2淋巴结解剖。随访CT揭示了肝转移,部分肝切除术在1998年1月进行。后,每周高剂量的肝内动脉化疗(5-FU:1,000mg /体)进行41次,但CT在10月显示多个肝转移酶因此,1998年11月给出了具有可降解的淀粉微球(DSM)的促乳霉素C(MMC)的肝脏内动脉输注。作为随访CT,揭示了肝转移率生长,部分肝切除术于1999年3月再次进行。在切除的肝脏中没有看到癌。在第二次肝切除术后,使用DSM的MMC内肝内动脉输注五次。没有看到复发证据。建议用DSM肝内动脉输注MMC,用于结直肠癌ASA第二线治疗的肝脏转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号